dermagold100 – first shockwave therapy system approved for skin lesions
MTS Europe GmbH and its partner, Tissue Regeneration Technologies, LLC. (TRT), are pioneers in the field of tissue regeneration. This partnership enables us to reach new milestones in our exploration of novel treatment methods in the field of dermatology. The Dermagold revolutionizes the treatment of chronic wounds and skin lesions by utilizing the biological effect of shock waves. The full potential of shock wave therapy is to date unknown, but MTS and TRT are on the cutting edge of research and development in this exciting field.
The lithowave360 CS concentrates on the essentials: Performance and Service. The system is a compact, transportable lithotripter suitable for the entire range of urologic applications. Its compact design makes the lithowave360 CS a perfect adjunct to any existing C-arm and lithotripsy table.
For more information on MTS please visit http://www.mts-medical.com.